Cargando…
Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
BACKGROUND: First reported in 1955, Cronkhite–Canada syndrome (CCS), a rare syndrome characterized by ectodermal abnormalities and inflammatory changes of the gastrointestinal tract mucosa, has been associated with a poor prognosis and life-threatening malignant complications. In a large population...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805704/ https://www.ncbi.nlm.nih.gov/pubmed/26216651 http://dx.doi.org/10.1007/s00535-015-1107-7 |
_version_ | 1782423188683096064 |
---|---|
author | Watanabe, Chikako Komoto, Shunsuke Tomita, Kengo Hokari, Ryota Tanaka, Masanori Hirata, Ichiro Hibi, Toshifumi Kaunitz, Jonathan D. Miura, Soichiro |
author_facet | Watanabe, Chikako Komoto, Shunsuke Tomita, Kengo Hokari, Ryota Tanaka, Masanori Hirata, Ichiro Hibi, Toshifumi Kaunitz, Jonathan D. Miura, Soichiro |
author_sort | Watanabe, Chikako |
collection | PubMed |
description | BACKGROUND: First reported in 1955, Cronkhite–Canada syndrome (CCS), a rare syndrome characterized by ectodermal abnormalities and inflammatory changes of the gastrointestinal tract mucosa, has been associated with a poor prognosis and life-threatening malignant complications. In a large population survey, we endeavored to characterize the course and treatment outcome of CCS through clinical and endoscopic assessment, and to explore its optimal treatment and surveillance strategy. METHODS: A retrospective analysis of 210 patients with CCS was conducted via a questionnaire-based nationwide survey of 983 teaching hospitals located throughout Japan. We assessed clinical features, endoscopic findings, treatments used, and short- and long-term outcomes. RESULTS: The average age at diagnosis was 63.5 years. In all cases, upper or lower gastrointestinal tract polyposis was confirmed, accompanied by characteristic ectodermal abnormalities. Of the treatments used, oral corticosteroids (30–49 mg/day) were the most effective treatment for active disease, with adjunctive nutritional support considered beneficial. With corticosteroid treatment, abdominal symptoms were relieved within a few months, whereas polyp regression often required more than 6 months. Maintenance of endoscopic remission with or without steroids for 3 years significantly lowered the development of CCS-related cancer, compared with relapsers or nonresponders, underscoring the importance of sustained endoscopic remission for cancer prevention. CONCLUSIONS: The prognosis of CCS has greatly improved through the use of improved medical treatment. Although CCS continues to be relentlessly progressive, carrying a high cancer risk, a sufficient dose and duration of corticosteroid therapy accompanied by nutritional support and periodic endoscopic surveillance appears to improve its natural history. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-015-1107-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4805704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-48057042016-04-09 Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey Watanabe, Chikako Komoto, Shunsuke Tomita, Kengo Hokari, Ryota Tanaka, Masanori Hirata, Ichiro Hibi, Toshifumi Kaunitz, Jonathan D. Miura, Soichiro J Gastroenterol Original Article—Alimentary Tract BACKGROUND: First reported in 1955, Cronkhite–Canada syndrome (CCS), a rare syndrome characterized by ectodermal abnormalities and inflammatory changes of the gastrointestinal tract mucosa, has been associated with a poor prognosis and life-threatening malignant complications. In a large population survey, we endeavored to characterize the course and treatment outcome of CCS through clinical and endoscopic assessment, and to explore its optimal treatment and surveillance strategy. METHODS: A retrospective analysis of 210 patients with CCS was conducted via a questionnaire-based nationwide survey of 983 teaching hospitals located throughout Japan. We assessed clinical features, endoscopic findings, treatments used, and short- and long-term outcomes. RESULTS: The average age at diagnosis was 63.5 years. In all cases, upper or lower gastrointestinal tract polyposis was confirmed, accompanied by characteristic ectodermal abnormalities. Of the treatments used, oral corticosteroids (30–49 mg/day) were the most effective treatment for active disease, with adjunctive nutritional support considered beneficial. With corticosteroid treatment, abdominal symptoms were relieved within a few months, whereas polyp regression often required more than 6 months. Maintenance of endoscopic remission with or without steroids for 3 years significantly lowered the development of CCS-related cancer, compared with relapsers or nonresponders, underscoring the importance of sustained endoscopic remission for cancer prevention. CONCLUSIONS: The prognosis of CCS has greatly improved through the use of improved medical treatment. Although CCS continues to be relentlessly progressive, carrying a high cancer risk, a sufficient dose and duration of corticosteroid therapy accompanied by nutritional support and periodic endoscopic surveillance appears to improve its natural history. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-015-1107-7) contains supplementary material, which is available to authorized users. Springer Japan 2015-07-28 2016 /pmc/articles/PMC4805704/ /pubmed/26216651 http://dx.doi.org/10.1007/s00535-015-1107-7 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article—Alimentary Tract Watanabe, Chikako Komoto, Shunsuke Tomita, Kengo Hokari, Ryota Tanaka, Masanori Hirata, Ichiro Hibi, Toshifumi Kaunitz, Jonathan D. Miura, Soichiro Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey |
title | Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey |
title_full | Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey |
title_fullStr | Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey |
title_full_unstemmed | Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey |
title_short | Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey |
title_sort | endoscopic and clinical evaluation of treatment and prognosis of cronkhite–canada syndrome: a japanese nationwide survey |
topic | Original Article—Alimentary Tract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805704/ https://www.ncbi.nlm.nih.gov/pubmed/26216651 http://dx.doi.org/10.1007/s00535-015-1107-7 |
work_keys_str_mv | AT watanabechikako endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT komotoshunsuke endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT tomitakengo endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT hokariryota endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT tanakamasanori endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT hirataichiro endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT hibitoshifumi endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT kaunitzjonathand endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey AT miurasoichiro endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey |